These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 24612178)

  • 21. A systematic examination of the 2013 ACC/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease.
    Karmali KN; Goff DC; Ning H; Lloyd-Jones DM
    J Am Coll Cardiol; 2014 Sep; 64(10):959-68. PubMed ID: 25190228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2013 ACC/AHA Guideline: a guideline for the population - without evidence from the population.
    Myerson M; Rosenson RS
    Cardiovasc Drugs Ther; 2014 Jun; 28(3):203-4. PubMed ID: 24610170
    [No Abstract]   [Full Text] [Related]  

  • 23. Importance of high-density lipoprotein cholesterol control during pravastatin treatment in hypercholesterolemic Japanese with type 2 diabetes mellitus: a post hoc analysis of MEGA study.
    Nishimura R; Sone H; Nakagami T; Tajima N
    Diabetes Res Clin Pract; 2013 May; 100(2):e31-3. PubMed ID: 23522341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction.
    Ito MK; Talbert RL; Tsimikas S
    Pharmacotherapy; 2006 Jul; 26(7 Pt 2):85S-97S; discussion 98S-101S; quiz 106S-108S. PubMed ID: 16803418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2013 ACC/AHA cholesterol treatment guideline: what was done well and what could be done better.
    Martin SS; Abd TT; Jones SR; Michos ED; Blumenthal RS; Blaha MJ
    J Am Coll Cardiol; 2014 Jun; 63(24):2674-8. PubMed ID: 24681146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new way to get heart-healthy. Recently released guidelines could change the way women are treated with statin drugs.
    Harv Womens Health Watch; 2014 Apr; 21(8):3. PubMed ID: 25097940
    [No Abstract]   [Full Text] [Related]  

  • 27. Accuracy of statin assignment using the 2013 AHA/ACC Cholesterol Guideline versus the 2001 NCEP ATP III guideline: correlation with atherosclerotic plaque imaging.
    Johnson KM; Dowe DA
    J Am Coll Cardiol; 2014 Sep; 64(9):910-9. PubMed ID: 25169177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New points and limits of 2013 American College of Cardiology/American Heart Association guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults].
    Ye P
    Zhonghua Nei Ke Za Zhi; 2014 Feb; 53(2):87-8. PubMed ID: 24767156
    [No Abstract]   [Full Text] [Related]  

  • 29. Letter by Stone et al regarding article, "perspective on the 2013 American Heart Association/American College of Cardiology guideline for the use of statins in primary prevention of low-risk individuals".
    Stone NJ; Lloyd-Jones DM; Blum C; Goff DC; Smith SC
    Circ Res; 2014 Jun; 115(1):e1-2. PubMed ID: 24951768
    [No Abstract]   [Full Text] [Related]  

  • 30. [Type 2 diabetic: risk same as after infarct. With LDL not only the quantity counts].
    MMW Fortschr Med; 2004 Jun; 146(24):4. PubMed ID: 15366509
    [No Abstract]   [Full Text] [Related]  

  • 31. Updated guidelines support even lower cholesterol levels for at-risk patients.
    Levenson D
    Rep Med Guidel Outcomes Res; 2004 Aug; 15(15):1, 6-7. PubMed ID: 15320342
    [No Abstract]   [Full Text] [Related]  

  • 32. Simvastatin reduces plasma osteoprotegerin in type 2 diabetic patients with microalbuminuria.
    Nellemann B; Gormsen LC; Dollerup J; Schmitz O; Mogensen CE; Rasmussen LM; Nielsen S
    Diabetes Care; 2007 Dec; 30(12):3122-4. PubMed ID: 17804683
    [No Abstract]   [Full Text] [Related]  

  • 33. Should family physicians follow the new ACC/AHA cholesterol treatment guideline? Not completely: why it is right to drop LDL-C targets but wrong to recommend statins at a 7.5% 10-year risk.
    Hayward RA
    Am Fam Physician; 2014 Aug; 90(4):223-4. PubMed ID: 25250995
    [No Abstract]   [Full Text] [Related]  

  • 34. [LDL cholesterol in cardiovascular risk patients should be as low as possible].
    MMW Fortschr Med; 2007 Oct; 149(41):44-5. PubMed ID: 17992793
    [No Abstract]   [Full Text] [Related]  

  • 35. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
    Bruckert E; Ferrières J
    Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneity in statin indications within the 2013 american college of cardiology/american heart association guidelines.
    Shah RV; Rubenfire M; Brook RD; Lima JA; Nallamothu B; Murthy VL
    Am J Cardiol; 2015 Jan; 115(1):27-33. PubMed ID: 25456869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New guidelines on treatment of blood cholesterol: too much of a good thing?].
    Lippi G; Mattiuzzi C
    Recenti Prog Med; 2014 Sep; 105(9):317-21. PubMed ID: 25229759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Summaries for patients. Control of lipids in patients with type 2 diabetes: recommendations from the American College of Physicians.
    Ann Intern Med; 2004 Apr; 140(8):I85. PubMed ID: 15096362
    [No Abstract]   [Full Text] [Related]  

  • 39. The new cardiovascular disease prevention guidelines: what you need to know.
    Campos-Outcalt D
    J Fam Pract; 2014 Feb; 63(2):89-93. PubMed ID: 24527471
    [No Abstract]   [Full Text] [Related]  

  • 40. Blood pressure, lipids and glucose in type 2 diabetes: how low should we go? Re-discovering personalized care.
    Rutter MK; Nesto RW
    Eur Heart J; 2011 Sep; 32(18):2247-55. PubMed ID: 21705358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.